levodopa has been researched along with lithium chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andersen, JK; Kim, YH; Lazzara, CA; Rane, A; Riley, RR | 1 |
| Guttuso, T | 1 |
3 other study(ies) available for levodopa and lithium chloride
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy.
Topics: Animals; Antiparkinson Agents; Brain Stem; Calpain; Carbidopa; Cell Death; Cell Line; Corpus Striatum; Dopaminergic Neurons; Drug Therapy, Combination; Histone Acetyltransferases; Levodopa; Lithium Chloride; Male; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Rats; Tyrosine 3-Monooxygenase | 2015 |
Low-dose lithium adjunct therapy associated with reduced off-time in Parkinson's disease: A case series.
Topics: Aged; Antiparkinson Agents; Female; Follow-Up Studies; Humans; Levodopa; Lithium Chloride; Male; Middle Aged; Parkinson Disease | 2016 |